SMAIO lists on Euronext Growth Paris

Philippe Roussouly, CEO and Founder of SMAIO, opens the trading day in Paris.

SMAIO is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates a large number of implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, SMAIO has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs.